Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Felizzi

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|September 26, 2012
Network-of-queues approach to B-cell-receptor affinity discriminationFederico Felizzi, Federico Comoglio
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|February 16, 2013
Enhanced cellular sensitivity from partitioning the integrin receptors into multiple clustersFederico Felizzi, Dagmar Iber
Ophthalmology and Therapy|September 29, 2022
A Social Media Listening Study to Understand the Unmet Needs and Quality of Life in Adult and Pediatric Amblyopia PatientsAnnie Syntosi, Federico Felizzi, Christine Bouchet
Pharmacoeconomics - Open|February 27, 2021
Mixture Cure Models in Oncology: A Tutorial and Practical GuidanceFederico Felizzi, Noman Paracha, Johannes Pöhlmann, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 31, 2013
Analyzing and constraining signaling networks: parameter estimation for the userFlorian Geier, Georgios Fengos, Federico Felizzi, et al.
Statistics in Medicine|July 29, 2020
Semiparametric estimation of the cure fraction in population-based cancer survival analysisEnnan Gu, Jiajia Zhang, Wenbin Lu, et al.
Journal of Medical Economics|January 18, 2020
Cost-effectiveness of atezolizumab versus docetaxel and nivolumab in the treatment of non-small cell lung cancer as a second line in FranceSivignon Marine, Roze Stéphane, Plommet Nicolas, et al.
Journal of Managed Care & Specialty Pharmacy|February 15, 2021
Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphomaScott J Spencer, Gregory F Guzauskas, Federico FeLizzi, et al.
Ophthalmology and Therapy|June 25, 2023
Qualitative Exploration of the Visual Function Impairments and Health-Related Quality of Life Impacts of Amblyopia in Adult and Pediatric PopulationsSharan Randhawa, Natasha Griffiths, Paul O'Brien, et al.
Ophthalmology and Therapy|February 24, 2023
The Amblyopia Quality of Life (AmbQoL): Development and Content Validation of a Novel Health-Related Quality of Life Instrument for Use in Adult and Pediatric Amblyopia PopulationsAnn Webber, Sharan Randhawa, Federico Felizzi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|September 26, 2012
Network-of-queues approach to B-cell-receptor affinity discriminationFederico Felizzi, Federico Comoglio
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|February 16, 2013
Enhanced cellular sensitivity from partitioning the integrin receptors into multiple clustersFederico Felizzi, Dagmar Iber
Ophthalmology and Therapy|September 29, 2022
A Social Media Listening Study to Understand the Unmet Needs and Quality of Life in Adult and Pediatric Amblyopia PatientsAnnie Syntosi, Federico Felizzi, Christine Bouchet
Pharmacoeconomics - Open|February 27, 2021
Mixture Cure Models in Oncology: A Tutorial and Practical GuidanceFederico Felizzi, Noman Paracha, Johannes Pöhlmann, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 31, 2013
Analyzing and constraining signaling networks: parameter estimation for the userFlorian Geier, Georgios Fengos, Federico Felizzi, et al.
Statistics in Medicine|July 29, 2020
Semiparametric estimation of the cure fraction in population-based cancer survival analysisEnnan Gu, Jiajia Zhang, Wenbin Lu, et al.
Journal of Medical Economics|January 18, 2020
Cost-effectiveness of atezolizumab versus docetaxel and nivolumab in the treatment of non-small cell lung cancer as a second line in FranceSivignon Marine, Roze Stéphane, Plommet Nicolas, et al.
Journal of Managed Care & Specialty Pharmacy|February 15, 2021
Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphomaScott J Spencer, Gregory F Guzauskas, Federico FeLizzi, et al.
Ophthalmology and Therapy|June 25, 2023
Qualitative Exploration of the Visual Function Impairments and Health-Related Quality of Life Impacts of Amblyopia in Adult and Pediatric PopulationsSharan Randhawa, Natasha Griffiths, Paul O'Brien, et al.
Ophthalmology and Therapy|February 24, 2023
The Amblyopia Quality of Life (AmbQoL): Development and Content Validation of a Novel Health-Related Quality of Life Instrument for Use in Adult and Pediatric Amblyopia PopulationsAnn Webber, Sharan Randhawa, Federico Felizzi, et al.
Pageof 2